Multifunctional Scaffold for Osteoporotic Pathophysiological Microenvironment Improvement and Vascularized Bone...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Nanotechnology

Background:

• Osteoporosis causes bone defects due to imbalanced osteoblast and osteoclast activity, leading to suppressed bone formation, increased bone resorption, and poor vascularization.
• Current treatments for osteoporotic bone defects face challenges due to the complex pathological microenvironment.
• Effective strategies require addressing multiple factors including osteogenesis, osteoclastogenesis, and angiogenesis.

Purpose of the Study:

• To construct a novel composite biomaterial for enhanced osteoporotic bone defect regeneration.
• To investigate the synergistic effects of combining a drug delivery system with a bone cement.
• To evaluate the potential of this composite in improving the osteoporotic microenvironment and promoting vascularized bone healing.

Main Methods:

• A drug carrier system of gelatin-coated hollow mesoporous silica nanoparticles (HMSNs/GM) was fabricated, loaded with parathyroid hormone (PTH) and alendronate (ALN).
• The HMSNs@ALN-PTH/GM nanoparticles were compounded into calcium magnesium phosphate cement (MCPC) to create the composite biomaterial (MCPC/HMSNs@ALN-PTH/GM).
• The in vivo efficacy was evaluated in ovariectomized rats, assessing bone regeneration, vascularization, osteogenic differentiation, osteoclastogenesis, and bone resorption.

Main Results:

• The MCPC composite exhibited controlled ion and drug release, tunable degradation, and a porous structure beneficial for bone regeneration.
• The composite significantly accelerated vascularization, promoted osteogenic differentiation and mineralization, and inhibited osteoclastogenesis and bone resorption in vivo.
• The MCPC/HMSNs@ALN-PTH/GM demonstrated a synergistic threefold effect, significantly improving the osteoporotic bone defect microenvironment.

Conclusions:

• The developed MCPC/HMSNs@ALN-PTH/GM composite biomaterial effectively promotes osteoporotic vascularized bone defect regeneration.
• This novel material holds significant potential for clinical applications in managing osteoporosis and designing future functional biomaterials.
• The synergistic approach addresses key pathological features of osteoporosis, offering a promising therapeutic strategy.